Oxidative stress has been associated with the carcinogenesis of colorectal cancer. Glutathione S-transferases (GSTs) modulate the elimination of free radical. We conducted a case-control study to examine the interaction between oxidative stress and GSTs polymorphisms on colorectal cancer risk. This study recruited 727 pathologically confirmed colorectal adenocarcinoma cases and 736 sex-and age-matched controls. Plasma protein carbonyls, as a parameter of oxidative stress, were measured using enzymelinked immunosorbent assay. Genotypes of GSTM1, GSTT1 and GSTP1 genes were determined using polymerase chain reaction methods. The protein carbonyl levels were significantly higher in cases than in controls and exerted a dose-response relationship (P for trend < 0.001). Compared with the first carbonyl quartile subjects, those in the second, third and fourth quartiles had odds ratios (ORs) of 1.54 [95% confidence interval (CI) 5 1.13-2.10], 1.52 (95% CI 5 1.11-2.07) and 1.98 (95% CI 5 1.46-2.67), respectively. This effect was significantly modified by GSTM1 genotype (P for interaction 5 0.037). The three-way interaction analysis revealed that interactions between GSTM1 genotype and cigarette smoking and between GSTT1 genotype and alcohol drinking further modified the oxidative stress contribution for colorectal cancer (p for interaction were 0.067 and 0.054, respectively). The impact of oxidative stress was more prominent among eversmokers with GSTM1-null genotype (OR 5 3.45, 95% CI 5 1.70-6.97) and ever-drinkers with GSTT1-present genotype (OR 5 3.87, 95% CI 5 1.82-8.25). Our results indicate that interaction between oxidative stress and GSTs polymorphisms may play an important role in the pathogenesis of colorectal cancer.
Introduction
Colorectal cancer is the third leading cause of cancer deaths for population in Taiwan (1) . Environmental factors, including dietary and lifestyle factors, play a crucial role in the etiology of colorectal cancer (2) . This disease is also attributable to inherited and acquired genetic alterations (3) .
It is well known that enhanced oxidative stress and inflammation are associated with an increased risk of cancer (4) . The gastrointestinal tract, especially the colon, is constantly exposed to reactive oxygen species (ROS) (5), generated during normal cellular metabolism and pathological processes (6) . ROS are responsible for DNA, lipid and protein damage and play an important role in the development and progression of many human diseases, including cancer (7) . A recent study has demonstrated an enhanced oxidative stress in neoplastic tissue for colorectal cancer patients as compared with normal intestinal tissue (8) .
Proteins are major targets of reactive oxidants in cells and oxidized proteins that accumulate during aging, accompanied with oxidative stress and some pathological conditions (7, 9) . Protein carbonyl content is actually the most commonly used marker of protein oxidation (9, 10) . Several methods are available to detect protein carbonyl groups, including a sensitive enzyme-linked immunosorbent assay method (11) .
Glutathione S-transferases (GSTs) catalyze the detoxification of many toxic xenobiotics by conjugation with glutathione (12) . Most GSTs substrates are thought as electrophiles and products of oxidative stress, i.e. ROS (13) . Numerous chemicals and ROS induce and modulate GSTs in vivo expression through gene antioxidant-and xenobiotic-responsive elements (14) . Therefore, GSTs may be important in the protection against oxidative stress (15) . GSTs are separated into the following classes: alpha (GSTA); mu (GSTM); pi (GSTP); theta (GSTT); sigma and kappa (16) . Functional polymorphisms known in most studies are GSTM1, GSTT1 and GSTP1 (17) . Our previous study has shown that men with both GSTT1 null and GSTP1 G allele genotypes are at significant risk of colorectal cancer [odds ratio (OR) 5 1.91, 95% confidence interval (CI) 5 1.21-3.02]. In addition, these two polymorphisms might interact with vegetable/fruit intake and cigarette smoking to modulate this cancer risk (18) .
The plasma protein carbonyl levels have been associated with the etiology of colorectal cancer. Di Giacomo et al. (19) measured the protein carbonyl levels in 54 patients with colorectal cancer, 32 patients with precancerous lesions (ulcerative colitis and polyposis) and 20 healthy subjects and found this marker was positively associated with the progression of colorectal cancer. Chang et al. (20) also observed higher levels of protein carbonyl in 36 colorectal cancer patients than in 40 healthy controls in a Chinese population (P , 0.01). Nevertheless, these studies were limited with small sample size and lacked for incorporating genetic factors that modulate oxidative stress. In a hospital-based case-control study of colorectal cancer, we assessed the risk associated with plasma protein carbonyls with a much larger sample, focusing on the modification of GSTs genotypes.
Materials and methods

Study population
The participant characteristics have been detailed previously (21) . In brief, participants were recruited from a medical center in northern Taiwan from January 1995 to January 1999. The colorectal adenocarcinoma cancer cases (n 5 776) participating in this study were newly diagnosed and histologically confirmed. Subsequent to excluding patients featuring familial adenomatous polyposis (n 5 11), hereditary non-polyposis colorectal cancer (n 5 18) or inflammatory bowel disease and other malignancies (n 5 20), a total of 727 cases (94%) were included in this study. During the same period, 747 age-and sex-matched potential controls were recruited from subjects who received a comprehensive health checkup at the same hospital. After excluding individuals diagnosed with other colorectal diseases, a history of other cancers or a family history of colorectal cancer, 736 controls (98%) were finally included in this study. The socio-demographic characteristics of study participants were ascertained using a structured questionnaire, and each participant provided a specimen of 10 ml venous blood. Both activities were conducted prior to the surgery for cases and the colonoscopy for controls. According to institutional guidelines, each subject was aware of the participation in the study and signed an informed consent form. (22) . Before analysis, plasma samples were adjusted to a protein concentration of 4 mg/ml (Bradford reagent; Sigma, St Louis, MO). Samples were derivatized with 2,4-dinitrophenylhydrazine (Sigma) and adsorbed to Maxisorb 96-well plates (Nunc, Life Technologies, Eggenstein, Germany). After blocking with 0.1% Tween 20, protein carbonyls were detected using a polyclonal rabbit anti-dinitrophenyl antibody (Molecular Probes, Eugene, OR; 1:2000 for 1 h at 37°C) and horseradish peroxidase-conjugated secondary antibody (GE Healthcare (formerly Amersham), Piscataway, NJ; 1:4000 for 1 h at 37°C). Immunoreactivity was determined by measuring the conversion of 3,3#,5,5#-tetramethylbenzidine (Sigma) at 450 nm after termination of the reaction with sulfuric acid. Hypochlorous acid-oxidized bovine serum albumin was used as external standard (11) . Results were expressed as picomole carbonyl per milligram plasma. The assay for the total carbonyl content had an interbatch coefficient of variation of 17% (n 5 37).
Genotyping
Genomic DNA was isolated from 10 ml blood using standard procedures with phenol-chloroform extraction. The polymorphisms were analyzed by polymerase chain reaction assays for GSTM1 and GSTT1 or combined with restriction fragment length polymorphism assays for GSTP1 A/G (Ile105Val). The details of genotyping methods were shown in our previous study (18) .
Statistical analysis
The data of general characteristics or protein carbonyl levels were expressed as mean ± SD. Distribution for GSTs genotypes were compared between cases and controls using the chi-square test. The differences between disease groups or GSTs genotypes for the mean plasma protein carbonyl levels were examined by Student's t-test or analysis of variance test. Unconditional logistic regression controlling for matching factor (age as continuous variable and sex) was used to calculate ORs and 95% CIs between protein carbonyl levels and colorectal cancer risk (23) . Other factors to be considered as potential confounders included those that have been associated with colorectal cancer and/or oxidative stress, such as physical activity, cigarette smoking, alcohol use and consumption of meat, vegetable/fruit and fish/shrimp. Because the causal relationships between those factors and plasma protein carbonyls levels have not been established, only those that had an impact .10% on the effect estimates were included in the final models. However, none of these factors met the inclusion criteria. We also conducted interaction analyses on the basis of a multiplicative scale to evaluate the interaction between protein carbonyl levels, GSTs genotypes and environment factors. All analyses were performed using the SAS statistical package (version 8.2 for windows; SAS Institute, Cary, NC) and P , 0.05 was used as the criterion for statistical significance. Table I shows the genotypic distributions of the three GSTs genes for study participants. The frequencies for the GSTM1 null, GSTT1 null and GSTP1 G allele amongst the controls were 0.56, 0.49 and 0.17, respectively. Only the GSTT1-null genotype was significantly higher in cases than in controls (0.55 versus 0.49, P 5 0.029).
Results
The mean of protein carbonyl levels stratified by GSTs genotypes in cases and controls are shown in Table II . For all participants, the mean protein carbonyl level was significantly higher in cases than in controls (P , 0.001) (101.9 ± 27.4 pmol carbonyls/mg plasma versus 97.0 ± 16.8 pmol carbonyls/mg plasma). Further stratified analysis by GSTs genotypes also showed that the means of oxidized protein in all genotypic strata were higher in cases than in controls. However, the carbonyl contents were not significantly different by GSTM1, GSTT1 and GSTP1 genotypes in both cases and controls, except that the mean carbonyl level in GSTM1-null genotype was moderately lower than that in present genotype among controls.
Protein carbonyl levels significantly increased the risk of colorectal cancer among our participants, even stratified by the general characteristics (Table III) . Compared with subjects with lowest quartile carbonyl levels, the ORs for the second, third and fourth quartiles of carbonyl levels were 1.54 (95% CI 5 1.13-2.10), 1.52 (95% CI 5 1.11-2.07) and 1.98 (95% CI 5 1.46-2.67) (P for trend , 0.001). A stronger risk of colorectal cancer was seen for women (OR 5 2.47, 95% CI 5 1.55-3.94) (data not shown). In addition, a much higher risk was observed among subjects without school education (OR 5 3.70, 95% CI 5 1.88-7.30) (P for interaction 5 0.0003). However, the association between protein carbonyls and colorectal cancer risk was not significantly modified by other characteristics. Table IV shows a significant modification effect of GSTM1 genotype on the association between carbonyl levels and colorectal cancer risk (P 5 0.037). The OR for individuals in the top quartile was enhanced to 2.54 (95% CI 5 1.69-3.81) among subjects carrying the GSTM1-null genotype. Subjects with the GSTT1-present genotype at the similar carbonyl level also had 2.34-fold risk of the disease (95% CI 5 1.49-3.68). However, these interactions were not significant for GSTT1 or GSTP1 genes.
In a three-way interaction analysis, we found a marginal interaction between GSTM1 genotype, cigarette smoking and protein carbonyl levels on the risk of colorectal cancer (P for interaction was 0.067) ( Table V) . The strongest impact of protein carbonyls on colorectal cancer was observed for ever-smokers with the GSTM1-null genotype (OR 5 3.45, 95% CI 5 1.70-6.97). However, the highest colorectal cancer risk for ever-smokers with the protein carbonyl levels of the fourth quartile was observed in the GSTT1-present genotype (OR 5 3.58, 95% CI 5 1.76-7.30).
The three-way interaction analyses were also conducted between GSTs genotypes, alcohol drinking and carbonyl levels (Table VI) . A similar interaction appeared between GSTT1 gene, alcohol drinking and carbonyl levels (P 5 0.054). However, the highest risk of colorectal cancer was observed among ever-alcohol drinkers carrying the GSTM1-null genotype (OR 5 4.02, 95% CI 5 1.89-8.54). No significant gene-gene interactions on the association between plasma Oxidative stress, GSTs polymorphism and colorectal caner protein carbonyls and colorectal cancer risk were found in the present study (data not shown).
Discussion
We found that the carbonyl contents in the plasma were significantly higher in colorectal cancer patients than in the matched controls. The increased risk associated with protein carbonyl levels was modified by
GSTs genotypes, which also interacted with cigarette smoking or alcohol drinking and altered the association between protein carbonyl levels and risk of colorectal cancer. Although the underlying mechanism of carcinogenesis induced by ROS is not clear, ROS have shown to possess many characteristics of carcinogens (24) . Several previous studies have observed increased levels of plasma protein carbonyl levels in patients with Hodgkin's lymphoma (25) , bladder cancer (26), prostate cancer (27), breast The cut-point of score for vegetable/fruit was 2, 3 and !4. The cut-point of score for fish/shrimp was 1, 2 and !3. C.-C.Yeh et al.
cancer (28) and in children with various malignancies (29) . Studies have also provided evidence that oxidative stress plays a role in carcinogenesis of colorectal cancer (4,5) and enhance leukocyte activation in the neoplastic tissues of the colon (8).
Our results support that GSTM1 and GSTT1 might have a role in the oxidative etiology of colorectal cancer. Various GSTs can utilize DNA and lipid products of oxidative stress but it is not clear how these reactions are co-ordinated in the cell under physiological or pathological conditions (14) . Although several studies have demonstrated an association between GSTs polymorphisms and colorectal cancer risk (18, (30) (31) (32) (33) (34) (35) , none have considered the role of oxidative stress in this association. In addition, polymorphisms in the GSTs genes have been correlated previously with various biomarkers of oxidative stress (36) (37) (38) . Since these enzymes are involved in the detoxification of a variety of electrophilic compounds, including oxidized lipids, DNA and catechol products generated by ROS, it can be postulated that individuals with less or null genotypes would be more susceptible to oxidative stress. However, no such relationship has been observed in other studies (39) (40) (41) .
With respect to GSTM1, we found that GSTM1-null genotype was significantly associated with higher colorectal cancer risk from oxidative stress. Individuals lacking GSTM1 are thought to have impaired ability to eliminate carcinogens or ROS from exogenous or endogenous environmental exposure, which lead to heightened oxidative stress. The role of GSTT1 genotype in the association between protein carbonyl levels and colorectal cancer risk is contrary to our hypothesis. The risk of colorectal caner-associated oxidative stress is increased among individuals carrying GSTT1-present genotype. Most studies have found that GSTT1-null genotype is related to increased colorectal cancer risk (18, (33) (34) (35) , whereas one study has reported a decreased risk associated with GSTT1-null genotype (32) . Furthermore, increased prevalence of the functional GSTT1 genotype has been observed in patients with pancreatitis (42), breast cancer (43), urothelial cancer (44) and cardiovascular disease (45) , which suggest that GSTT1-present genotype may exert an harmful effect for these diseases.
Studies have suggested that GSTT1 may activate some carcinogens produced by cigarette smoking (14,46,47) . Individuals with the Our results have also shown the modification role of GSTs polymorphisms in the association between protein carbonyl levels and colorectal cancer risk can be modulated by the use of cigarette and alcohol (Tables V and VI) . Smokers with GSTM1-null genotype and alcohol drinkers with GSTT1-present genotype acquired the highest oxidative stress for colorectal cancer. Although the combined role of GSTM1 genotype and cigarette smoking in plasma protein carbonyls is not available from the literature, several pervious studies have found that smokers with GSTM1-null genotype have a higher oxidative DNA damage than non-smokers with GSTM1-present genotype (36, 38, 49, 50) . Individuals inheriting deficient GSTM1 enzyme may have more accumulated non-detoxified carcinogens and increased burdens of reactive metabolites from smoking, causing increased oxidative stress and elevated the risk of colorectal cancer. In addition, the GSTM1-null genotype has been found to increase the frequency of chromosome aberrations after tobacco-specific N-nitrosamine exposure in vitro (51) . Therefore, it is conceivable that GSTM1-null genotype may interact with cigarette smoking to modulate the oxidative stress of colorectal cancer. This study provides some support to the hypothesis that GSTM1 protects against the oxidative effects of smoking (52) .
In the case of alcohol use, we also observed that GSTs polymorphisms may have a significant role of interacting with alcohol drinking for the colorectal cancer risk associated with protein carbonyls. No previous studies have reported such a three-way gene-environment interaction and colorectal cancer risk to date. Our finding may be partly supported by the study of Rahman et al. (48) , in which GSTT1-present genotype is associated with severe acute pancreatitis patients with higher C-reactive protein levels and acute physiology scores but lower erythrocyte glutathione concentration. They also found an inverse correlation between alcohol use and glutathione concentration (r 5 À0.91, P , 0.001), suggesting alcohol drinking and GSTT1 polymorphism may interactively affect the susceptibility to acute pancreatitis. In addition, Rossner et al. (28) have recently found a statistically significant trend in breast cancer risk in relation to increased plasma protein carbonyl levels among women with higher alcohol consumption. Although, toxicological studies in vivo and in vitro have shown inconsistent results on whether or not alcohol alters GSTs expression (53) , several studies have demonstrated an interaction between GSTs polymorphisms and alcohol consumption on cancer risk (54) . Further study on the combined role of GSTT1 genotype and alcohol drinking in protein carbonyl levels is worth to clarify the oxidative stress driving from alcohol consumption.
The present study has a number of strengths including relatively large sample size, precise measurement of protein carbonyls and simultaneous determination for several GSTs polymorphisms. Limitations included the collection of blood specimens after the disease diagnosed. We therefore cannot determine whether protein carbonyls are increased because of the progress of cancer. We have compared the protein carbonyl levels by tumor stage and found no significant difference (analysis of variance test P 5 0.074). In addition, it has been shown that surgery may result significantly decreased oxidative stress markers in colon cancer patients (19) . Several extensive efforts have been undertaken for this study to recruit newly diagnosed and histologically confirmed patients and to collect blood samples before the surgery for cases and colonoscopy for controls. The other limitation is that this study has not assessed whether health status and nutrition are confounders. Some antioxidants may decrease oxidative stress-associated neurological and inflammatory disease (55) . However, Mesia-Vela et al. (56) have found no association between protein carbonyl and chronic obstructive pulmonary disease, even after controlling for the use of antioxidant supplementation. In addition, protein carbonyls were measured from specimens that had been stored for several years at À80°C; it is probably that protein will be gradually oxidized during storage. However, Nagler et al. (57) have demonstrated the stability of protein carbonyls in frozen condition. Finally, the generalizability of our study is limited to Chinese population in Taiwan, as potential association between oxidative stress and colorectal cancer risk may be modified by GSTs genes that differ in prevalence among ethnic groups.
In conclusion, this study found the protein carbonyl levels are higher in patients with colorectal cancer than in the age-and sex-matched healthy controls. The level of oxidative stress has an important role in the etiology of colorectal cancer for Chinese population. The interactions between GSTs polymorphisms and cigarette smoking or alcohol drinking suggest that other genetic or environmental factors may modify the role of protein carbonyls. Further studies using other biomarkers of oxidative stress, including lipid peroxidation and oxidized DNA damage, may confirm the role of oxidative stress in relation to colorectal cancer risk among ethnic groups. 
